RCW Kansas – Relapsed Therapy and Clinical Trials

Dr. Al-Ola Abdallah, The University of Kansas Cancer Center, discusses the treatment of relapsed and refractory multiple myeloma, the classifications of available therapies, and new therapies on the horizon, including ide-cel, a B-cell maturation antigen (BCMA) targeted CAR T-cell therapy.

This International Myeloma Foundation Regional Community Workshop is a virtual workshop, set in an engaging environment that offers myeloma patients and caregivers up-to-the- minute information about multiple myeloma. Topics include an introduction to myeloma (Myeloma 101), upfront treatments at diagnosis, maintenance therapy, relapse information, and an update on clinical trials. Also, a member of the IMF Nurse Leadership Board will talk about managing side effects and symptoms of myeloma and treatments.

Download the Slides: http://bit.ly/rcw-kansas-21

Please subscribe to our channel!
Subscribe to International Myeloma Foundation: http://bit.ly/XlUtPE

Visit our website at: https://www.myeloma.org

Find us online:
Facebook: https://facebook.com/myeloma
Twitter: @IMFMyeloma (https://twitter.com/IMFmyeloma)
Instagram: @imfmyeloma (https://www.instagram.com/imfmyeloma)
LinkedIn: https://www.linkedin.com/company/international-myeloma-foundation)

Support the IMF! http://bit.ly/WskQHC
Category
Nonprofits & Activism
License
Standard YouTube License

source

by International Myeloma Foundation

linux foundation